Transaction in Own Shares

AI SummaryClose X

On 17 November 2026 RTW Biotech Opportunities bought back 106,811 ordinary shares at $2.44 each, to be held in treasury; following settlement issued share capital is 345,967,440 with 28,777,617 treasury shares (8.32%) and total voting rights of 317,189,823. The repurchase equals approximately 0.0309% of issued shares and was conducted under shareholder authority allowing repurchases of up to 14.99%; the company intends to hold repurchased shares in treasury and will not pay above net asset value for shares.

Disclaimer*

UK 100

Latest directors dealings